Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Surveillance Study Ultravist®-IMAGE IoproMide (UltrAvist®) to Gain Further Information on Tolerability and Safety in X-ray Examination

NCT00876083 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00876083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00876083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Surveillance Study Ultravist®-IMAGE IoproMide (UltrAvist®) to Gain Further Information on Tolerability and Safety in X-ray Examination
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
March 31, 2008
Completion date
September 30, 2009
Enrollment
44,920 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

diagnostic imaging